BridgeMD
Compares treatment options for Proximal Cavities of Posterior Teeth
Official title Clinical Performance of a Novel Self-cured Resin Composite Compared to a Light-cured Bioactive Resin Composite Restoration in Proximal Cavities of Posterior Teeth
ClinicalTrials.gov ID: NCT07457749
What this study is testing
What is Stela, SDI, Australia?
Stela, SDI, Australia is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for proximal cavities of posterior teeth.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The development of dental caries is multi-factorial mainly due to the presence of 4 elements which are: dental biofilm, fermentable carbohydrates , dental hard tissue and time. Other additional social and environmental factors can have a substantial impact on the onset and course of the disease.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 47
You may be able to join if
- people between the ages of 18-47 years old
- Primary caries removal
- Good or moderate oral hygiene
- Free of periodontal diseases (probing depth and attachment levels within normal limits/ no furcation involvement/ no mobility)
- Cooperative patients who agree to keep the scheduled recall appointments for data collection and maintenance
You likely can't join if
- Composite or amalgam removal
- Caries extended to the cemento-enamel junction in Class II caries
- Grade II or III mobility
- Considerable periodontal disease without treatment
- Endodontically treated teeth with extensive loss of tooth tissues
- Severe wear facets and/or parafunctional activities as clenching or nocturnal bruxism.
See the full eligibility criteria
- people between the ages of 18-47 years old
- Primary caries removal
- Good or moderate oral hygiene
- Free of periodontal diseases (probing depth and attachment levels within normal limits/ no furcation involvement/ no mobility)
- Cooperative patients who agree to keep the scheduled recall appointments for data collection and maintenance
- Composite or amalgam removal
- Caries extended to the cemento-enamel junction in Class II caries
- Grade II or III mobility
- Considerable periodontal disease without treatment
- Endodontically treated teeth with extensive loss of tooth tissues
- Severe wear facets and/or parafunctional activities as clenching or nocturnal bruxism.
- people who are pregnant during the duration of the study
- people with high caries activity
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, El Sherouk City, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 47 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, El Sherouk City, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.